Artwork

Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Rewind: Can Exercise Slow Parkinson's Disease Progression? with Daniel Corcos, PhD

24:42
 
Share
 

Manage episode 354623474 series 2399388
Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Parkinson's disease is the second most prevalent neurodegenerative disease, and nearly one million people have Parkinson's disease in the U.S. A $30 million dollar, phase 3 clinical trial at Northwestern is investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences, is leading the trial and explains what he hopes to accomplish.

Interested in the study? Learn more: https://www.feinberg.northwestern.edu/research/clinical-research/trials/index.html?id=STU00211903

  continue reading

108 episodes

Artwork
iconShare
 
Manage episode 354623474 series 2399388
Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Parkinson's disease is the second most prevalent neurodegenerative disease, and nearly one million people have Parkinson's disease in the U.S. A $30 million dollar, phase 3 clinical trial at Northwestern is investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences, is leading the trial and explains what he hopes to accomplish.

Interested in the study? Learn more: https://www.feinberg.northwestern.edu/research/clinical-research/trials/index.html?id=STU00211903

  continue reading

108 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide